ArticleBMJ open2018

Oral propranolol for prevention of threshold retinopathy of prematurity (ROPROP): protocol of a randomised controlled trial.

Christoph Bührer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.